These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28836530)

  • 1. Sialic acid as a biomarker of oral potentially malignant disorders and oral cancer.
    Achalli S; Madi M; Babu SG; Shetty SR; Kumari S; Bhat S
    Indian J Dent Res; 2017; 28(4):395-399. PubMed ID: 28836530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary L-fucose as a biomarker for oral potentially malignant disorders and oral cancer.
    Sharma M; Sharma E; Prabhu V; Pai VR; D'souza JM; Harish S; Jose M
    J Cancer Res Ther; 2020; 16(3):546-550. PubMed ID: 32719265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum sialic acid, sialyltransferase and sialoproteins in oral cavity cancer.
    Raval GN; Patel DD; Parekh LJ; Patel JB; Shah MH; Patel PS
    Oral Dis; 2003 May; 9(3):119-28. PubMed ID: 12945593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A non-invasive study to estimate and compare salivary sialic acid level as tumor marker in patients with pre-cancer and oral cancer.
    Jacob TV; Ramesh M; Murali S; Ramesh K; Sanjay PR; Abraham P
    J Cancer Res Ther; 2016; 12(2):634-9. PubMed ID: 27461623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of salivary sialic acid, total protein, and total sugar in oral cancer: a preliminary report.
    Sanjay PR; Hallikeri K; Shivashankara AR
    Indian J Dent Res; 2008; 19(4):288-91. PubMed ID: 19075429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the levels of salivary paxillin in oral potentially malignant disorders and malignant lesions.
    Hussine AA; Selim K; Shaker O; Kamal Y
    BMC Oral Health; 2024 Jul; 24(1):834. PubMed ID: 39048985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serum and salivary total sialic acid and α-l-fucosidase in patients with oral precancerous conditions and oral cancer.
    Vajaria BN; Patel KR; Begum R; Shah FD; Patel JB; Shukla SN; Patel PS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Jun; 115(6):764-71. PubMed ID: 23570662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of serum and salivary sialic acid in oral cancer diagnostics.
    Guruaribam VD; Sarumathi T
    J Cancer Res Ther; 2020; 16(3):401-404. PubMed ID: 32719243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Salivary Sialic Acid a Reliable Biomarker in the Detection of Oral Potentially Malignant Disorder and Oral Squamous Cell Carcinoma.
    Daniel D; Jose J; Harish Kumar A
    J Maxillofac Oral Surg; 2021 Mar; 20(1):83-89. PubMed ID: 33584047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of salivary sialic acid as a tumor marker in tobacco chewers with oral cancer.
    Azeem MS; Yesupatham ST; Mohiyuddin SMA; Sumanth V; Ravishankar S
    J Cancer Res Ther; 2020; 16(3):605-611. PubMed ID: 32719275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and salivary sialic acid as a biomarker in oral potentially malignant disorders and oral cancer.
    Dadhich M; Prabhu V; Pai VR; D'Souza J; Harish S; Jose M
    Indian J Cancer; 2014; 51(3):214-218. PubMed ID: 25494107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma.
    Rajkumar K; Ramya R; Nandhini G; Rajashree P; Ramesh Kumar A; Nirmala Anandan S
    Oral Dis; 2015 Jan; 21(1):90-6. PubMed ID: 24304502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and salivary interleukin-1β level in oral precancer: An observational study.
    Selvan TT; Patil RK; Singh V; Verma S; Tripathi A; Khanna V; Chaurasia A; Shetye AG
    J Cancer Res Ther; 2024 Apr; 20(3):788-792. PubMed ID: 39023584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary metabolomics in oral potentially malignant disorders and oral cancer patients-a systematic review with meta-analysis.
    Nazar NSBM; Ramanathan A; Ghani WMN; Rokhani FB; Jacob PS; Sabri NEB; Hassan MS; Kadir K; Dharmarajan L
    Clin Oral Investig; 2024 Jan; 28(1):98. PubMed ID: 38225483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of salivary sialic acid levels in acute lymphoblastic leukemic children and its correlation with dental caries experience.
    Joshi S; Hegde AM; Rai K; Shetty S
    J Clin Pediatr Dent; 2013; 37(3):309-13. PubMed ID: 23855178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the relationship between passive smoking and salivary electrolytes, protein, secretory IgA, sialic acid and amylase in young children.
    Avşar A; Darka O; Bodrumlu EH; Bek Y
    Arch Oral Biol; 2009 May; 54(5):457-63. PubMed ID: 19249013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of serum biomarkers (TSA & LSA) and epithelial dysplasia in early diagnosis of oral precancer and oral cancer.
    Sawhney H; Kumar CA
    Cancer Biomark; 2011-2012; 10(1):43-9. PubMed ID: 22297551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary sialic acid levels and dental health in children with congenital heart disease.
    Hegde AM; Kavita R; Sushma KS; Suchetha S
    J Clin Pediatr Dent; 2012; 36(3):293-6. PubMed ID: 22838234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels in serum of total sialic acid, lipid-associated sialic acid, and fucose in precancerous lesion and cancer of the oral cavity.
    Rao VR; Krishnamoorthy L; Kumaraswamy SV; Ramaswamy G
    Cancer Detect Prev; 1998; 22(3):237-40. PubMed ID: 9618045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ratio of Salivary Sialic Acid to Fucose as Tumor Markers in Potentially Malignant Disorders and Oral Cancer.
    Arthisri AS; Sathiyamoorthy A; Meenakshi B; Chandran CR
    Contemp Clin Dent; 2020; 11(2):131-135. PubMed ID: 33110325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.